165 related articles for article (PubMed ID: 2208382)
41. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
42. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
Takatori T; Shimono N; Higaki K; Kimura T
Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
[TBL] [Abstract][Full Text] [Related]
43. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
Watanabe Y; Tone Y; Suzuki M; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
[No Abstract] [Full Text] [Related]
44. [Dissolution and pharmacokinetic studies on controlled release indomethacin suppository].
Zhang YH; Liu GH; Ping QN
Yao Xue Xue Bao; 1987 Aug; 22(8):580-5. PubMed ID: 3450161
[No Abstract] [Full Text] [Related]
45. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
Onyeji CO; Adebayo AS; Babalola CP
Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
[TBL] [Abstract][Full Text] [Related]
46. Development of doxycycline hyclate suppositories and pharmacokinetic study in rabbits.
Christ AP; Biscaino PT; Lourenço RL; de Souza AB; Zimmermann ES; Adams AIH
Eur J Pharm Sci; 2020 Jan; 142():105141. PubMed ID: 31706017
[TBL] [Abstract][Full Text] [Related]
47. Development and evaluation of immediate release diclofenac sodium suppositories.
Sultan T; Hamid S; Hassan S; Hussain K; Ahmed A; Bashir L; Naz S; Maqbool T
Pak J Pharm Sci; 2018 Sep; 31(5):1791-1795. PubMed ID: 30150172
[TBL] [Abstract][Full Text] [Related]
48. Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R
N Z Med J; 1981 Apr; 93(682):261-2. PubMed ID: 7019782
[TBL] [Abstract][Full Text] [Related]
49. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
[TBL] [Abstract][Full Text] [Related]
50. Chloroquine absorption in children from polyethylene glycol base suppositories.
Okor RS; Nwankwo MU
J Clin Pharm Ther; 1988 Jun; 13(3):219-23. PubMed ID: 3209629
[TBL] [Abstract][Full Text] [Related]
51. Clinical pharmacokinetic comparison of two indometacin containing suppositories with different vehicula.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A
Arzneimittelforschung; 1984; 34(4):523-5. PubMed ID: 6547611
[TBL] [Abstract][Full Text] [Related]
52. Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Koishi M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1201-6. PubMed ID: 3607943
[No Abstract] [Full Text] [Related]
53. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application.
Ikeuchi-Takahashi Y; Sasatsu M; Onishi H
Int J Pharm; 2013 Sep; 453(2):454-61. PubMed ID: 23791737
[TBL] [Abstract][Full Text] [Related]
55. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
[TBL] [Abstract][Full Text] [Related]
56. Biopharmaceutical characteristics of a suppository base containing poly (oxyethylene)-poly (oxypropylene) copolymer, Unilube. I. Effects of a suppository base containing Unilube 70DP-950B on release and rectal absorption of aminopyrine in rabbit.
Itoh S; Morishita N; Yamazaki M; Suginaka A; Tanabe K; Sawanoi M
J Pharmacobiodyn; 1987 Apr; 10(4):173-9. PubMed ID: 3656064
[TBL] [Abstract][Full Text] [Related]
57. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
[TBL] [Abstract][Full Text] [Related]
58. The morphine hydrogel suppository. A new sustained release rectal preparation.
Hanning CD; Vickers AP; Smith G; Graham NB; McNeil ME
Br J Anaesth; 1988 Aug; 61(2):221-7. PubMed ID: 3415895
[TBL] [Abstract][Full Text] [Related]
59. Absorption and distribution of radioactivity from suppositories containing 3H-benzocaine in rats.
Ayres JW; Lorskulsint D; Lock A; Kuhl L; Laskar PA
J Pharm Sci; 1976 Jun; 65(6):832-8. PubMed ID: 932967
[TBL] [Abstract][Full Text] [Related]
60. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
